Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06432075 | Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer | not yet recruiting | Early Phase 1 | 20 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 0 | May 29, 2024 | clinicaltrials |
| NCT06426654 | Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer | not yet recruiting | Phase 1 / Phase 2 | 45 | West China HospitalOTHER | 0 | May 23, 2024 |
| NCT06421220 | Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer | not yet recruiting | N/A | 484 | Qilu Hospital of Shandong UniversityOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06384300 | Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China | not yet recruiting | N/A | 5,000 | Peking UniversityOTHER | 0 | Apr 25, 2024 | clinicaltrials |
| NCT06374901 | Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment. | not yet recruiting | Phase 2 | 134 | Xiangdong ChengOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06349967 | Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer | not yet recruiting | Phase 2 | 59 | West China HospitalOTHER | 0 | Apr 5, 2024 | clinicaltrials |
| NCT06339216 | A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer. | not yet recruiting | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 0 | Apr 1, 2024 | clinicaltrials |
| NCT06335576 | Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application | not yet recruiting | — | 89 | Shanghai Zhongshan HospitalOTHER | 0 | Mar 28, 2024 | clinicaltrials |
| NCT06310473 | Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial | not yet recruiting | Phase 2 | 30 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06295094 | The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.(EPICURE) | not yet recruiting | Phase 2 | 264 | Odense University HospitalOTHER | 5 | Mar 6, 2024 | clinicaltrials |
| NCT06283121 | A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer | not yet recruiting | Phase 2 | 30 | China Medical University, ChinaOTHER | 0 | Feb 29, 2024 | clinicaltrials |
| NCT06238167 | Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC | not yet recruiting | Phase 2 | 40 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 0 | Feb 2, 2024 | clinicaltrials |
| NCT06229197 | Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer | not yet recruiting | N/A | 176 | Sichuan UniversityOTHER | 0 | Jan 29, 2024 | clinicaltrials |
| NCT06213519 | HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis | not yet recruiting | Phase 2 | 69 | Sichuan UniversityOTHER | 0 | Jan 19, 2024 | clinicaltrials |
| NCT06115629 | Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) Trial(SARONG-II) | not yet recruiting | Phase 3 | 952 | University of Dublin, Trinity CollegeOTHER | 5 | Nov 3, 2023 | clinicaltrials |
| NCT06094868 | Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer | not yet recruiting | Phase 2 | 45 | Second Affiliated Hospital of Nanchang UniversityOTHER | 0 | Oct 23, 2023 | clinicaltrials |
| NCT05318794 | Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer(SPECTRA) | not yet recruiting | Phase 2 | 20 | Imperial College LondonOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05914610 | Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer | not yet recruiting | Phase 3 | 100 | Fujian Medical UniversityOTHER | 0 | Aug 25, 2023 | clinicaltrials |
| NCT05978882 | Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4) | not yet recruiting | N/A | 203 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05970627 | Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | not yet recruiting | Phase 2 | 30 | Yu jirenOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05959226 | Effect of Exercise and Enteral Nutrition on Survival(ENERGY) | not yet recruiting | N/A | 960 | The First Hospital of Jilin UniversityOTHER | 0 | Jul 25, 2023 | clinicaltrials |
| NCT05934058 | Genomic and Dietary Aspects in Gastric Cancer Risk(GenoStoP) | not yet recruiting | — | 383,980 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05747482 | Omentectomy vs Omental Preservation in Resectable Cancer | not yet recruiting | N/A | 569 | Corporacion Parc TauliOTHER | 0 | Feb 28, 2023 | clinicaltrials |
| NCT05447234 | TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy | not yet recruiting | Early Phase 1 | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Feb 16, 2023 | clinicaltrials |
| NCT05661110 | Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis | not yet recruiting | — | 46 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 0 | Dec 22, 2022 | clinicaltrials |
| NCT05648487 | HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis | not yet recruiting | Phase 2 | 46 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 0 | Dec 16, 2022 | clinicaltrials |
| NCT05300945 | HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy | not yet recruiting | Phase 2 / Phase 3 | 200 | Zhixin CaoOTHER | 0 | Dec 6, 2022 | clinicaltrials |
| NCT05610332 | Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes | not yet recruiting | Phase 3 | 216 | Fujian Medical UniversityOTHER | 1 | Nov 9, 2022 | clinicaltrials |
| NCT05524974 | Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes | not yet recruiting | Phase 2 | 203 | Fujian Medical UniversityOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT05369117 | Application of Indocyanine Green Labeled Fluorescent Laparoscopy in Proximal Gastric Cancer | not yet recruiting | N/A | 1,016 | Guangyong ZhangOTHER | 0 | May 27, 2022 | clinicaltrials |
| NCT05356156 | The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical Gastrectomy | not yet recruiting | N/A | 1,968 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT05230771 | Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer | not yet recruiting | Phase 3 | 120 | Fujian Medical UniversityOTHER | 0 | Apr 1, 2022 | clinicaltrials |
| NCT05270824 | Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma | not yet recruiting | Phase 3 | 120 | Fujian Medical UniversityOTHER | 0 | Mar 8, 2022 | clinicaltrials |
| NCT05235932 | the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer | not yet recruiting | N/A | 570 | Fujian Medical UniversityOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT04384601 | Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | not yet recruiting | Phase 3 | 246 | Ruijin HospitalOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04795063 | Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer | not yet recruiting | N/A | 160 | Fujian Medical UniversityOTHER | 1 | Mar 12, 2021 | clinicaltrials |
| NCT04677673 | Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients(RJGC-Senile) | not yet recruiting | Phase 2 / Phase 3 | 232 | BIRENDRA KUMAR SAHOTHER | 0 | Dec 21, 2020 | clinicaltrials |
| NCT04168346 | Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer(IRONSTOMACH) | not yet recruiting | Phase 4 | 202 | Helsinki University Central HospitalOTHER | 0 | Nov 19, 2019 | clinicaltrials |
| NCT03857737 | Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer | not yet recruiting | N/A | 300 | Peking University Third HospitalOTHER | 1 | Feb 28, 2019 | clinicaltrials |
Data updated 22 days agoSource updated May 29, 2024source: clinicaltrials